. 2015 Oct 31;10(4):509–516. doi: 10.1016/j.molonc.2015.10.010

Table 2.

Survival.

	Patients	Overall survival				Breast cancer specific survival				Relapse‐free survival
	Patients	Events	HR	95% CI	p‐Value	Events	HR	95% CI	p‐Value	Events	HR	95% CI	p‐Value
IGFR low
TAM → EXE	402	75	Ref		0.6	52	Ref		0.66	68	Ref		0.73
EXE	428	84	1.08	(0.81–1.43)		46	1.09	(0.74–1.63)		76	1.06	(0.76–1.47)
IGFR high
TAM → EXE	822	142	Ref		0.1	92	Ref		0.06	142	Ref		0.02
EXE	794	118	0.83	(0.66–1.04)		67	0.74	(0.54–1.01)		105	0.74	(0.58–0.95)